Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS)
INR 61.89
(1.13%)
INR 61.89
(1.13%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 400.35 Million | 300.35 Million | 223.82 Million | 357.5 Million | 296.9 Million | 231.28 Million |
| Cost of Revenue | 387.8 Million | 278.96 Million | 194.6 Million | 324.26 Million | 253.08 Million | 199.92 Million |
| Gross Profit | 12.54 Million | 21.38 Million | 29.21 Million | 33.23 Million | 43.81 Million | 31.36 Million |
| Operating Expenses | 6.82 Million | 14 Million | 20.16 Million | 21.36 Million | 29.66 Million | 24.77 Million |
| Selling, General and Administrative Expenses | 6.82 Million | 3.47 Million | 1.92 Million | 1.84 Million | 5.11 Million | 4.72 Million |
| Research and Development Expenses | - | - | - | 104 Thousand | 224 Thousand | 118 Thousand |
| Other Expenses | - | 970 Thousand | 1.29 Million | 7.75 Million | 1.49 Million | 799 Thousand |
| Cost and Expenses | 400.35 Million | 292.96 Million | 214.77 Million | 345.63 Million | 282.75 Million | 224.7 Million |
| Operating Income | 20.65 Million | 8.34 Million | 10.34 Million | 19.62 Million | 15.64 Million | 7.37 Million |
| Interest Expense | 415 Thousand | 425 Thousand | 390 Thousand | 642 Thousand | 1.21 Million | 1.6 Million |
| Income Tax Expense | 1.56 Million | 2.32 Million | 3.16 Million | 6.77 Million | 2.56 Million | 1.16 Million |
| Earnings before Tax | 8.65 Million | 7.93 Million | 10.14 Million | 19.18 Million | 14.64 Million | 5.98 Million |
| Net Income | 7.09 Million | 5.6 Million | 6.98 Million | 12.41 Million | 12.07 Million | 4.82 Million |
| Earnings Per Share Basic | 0.44 | 0.34 | 0.43 | 0.76 | 0.74 | 0.30 |
| Earnings Per Share Diluted | 0.44 | 0.34 | 0.43 | 0.76 | 0.74 | 0.30 |
| Weighted Average Shares Outstanding | 16.11 Million | 16.27 Million | 16.27 Million | 16.27 Million | 16.27 Million | 16.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.11 Million | 16.27 Million | 16.27 Million | 16.27 Million | 16.27 Million | 16.27 Million |
| Gross Margin | 0.03 | 0.07 | 0.13 | 0.09 | 0.15 | 0.14 |
| EBIT Margin | 0.03 | 0.04 | 0.07 | 0.07 | 0.07 | 0.05 |
| Profit Margin | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.02 |
| EBITDA | 12.99 Million | 12.64 Million | 14.83 Million | 23.74 Million | 19.73 Million | 11.02 Million |
| Earnings Before Tax Margin | 0.05 | 0.03 | 0.05 | 0.05 | 0.05 | 0.03 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 84.43 Million | 152.02 Million | 400.35 Million | 50.31 Million | 173.67 Million | 24.33 Million |
| Cost of Revenue | 79.52 Million | 150.09 Million | 385.77 Million | 44.62 Million | 168.6 Million | 17.29 Million |
| Gross Profit | 4.9 Million | 1.93 Million | 14.57 Million | 5.68 Million | 5.07 Million | 7.03 Million |
| Operating Expenses | 2.81 Million | 3.03 Million | 10.4 Million | 4.83 Million | 3.76 Million | 3.93 Million |
| Selling, General and Administrative Expenses | 2.81 Million | 3.03 Million | - | 2.27 Million | 1.06 Million | 1.25 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 294 Thousand | 4.05 Million | 4.89 Million | 279 Thousand | 315 Thousand | 247 Thousand |
| Cost and Expenses | 82.34 Million | 153.12 Million | 396.18 Million | 49.45 Million | 172.36 Million | 21.23 Million |
| Operating Income | 2.09 Million | -1.1 Million | 4.17 Million | 1.13 Million | 1.62 Million | 3.35 Million |
| Interest Expense | 107 Thousand | 209 Thousand | 415 Thousand | 1000.00 | 97 Thousand | 109 Thousand |
| Income Tax Expense | 587 Thousand | 261 Thousand | 1.56 Million | 200 Thousand | 300 Thousand | 800 Thousand |
| Earnings before Tax | 2.28 Million | 2.74 Million | 8.65 Million | 1.13 Million | 1.52 Million | 3.24 Million |
| Net Income | 1.69 Million | 2.48 Million | 7.09 Million | 933 Thousand | 1.22 Million | 2.44 Million |
| Earnings Per Share Basic | 0.10 | 0.15 | - | 0.06 | 0.08 | 0.15 |
| Earnings Per Share Diluted | 0.10 | 0.15 | - | 0.06 | 0.08 | 0.15 |
| Weighted Average Shares Outstanding | 16.27 Million | 16.27 Million | 16.11 Million | 16.27 Million | 16.27 Million | 16.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.27 Million | 16.27 Million | 16.11 Million | 16.27 Million | 16.27 Million | 16.27 Million |
| Gross Margin | 0.06 | 0.01 | 0.04 | 0.11 | 0.03 | 0.29 |
| EBIT Margin | 0.04 | -0.00 | - | 0.04 | 0.02 | 0.18 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.10 |
| EBITDA | 3.08 Million | -326 Thousand | - | 2.2 Million | 2.69 Million | 4.42 Million |
| Earnings Before Tax Margin | 0.02 | -0.01 | 0.01 | 0.02 | 0.01 | 0.14 |
LEOF
3266
ZWIPE
CTL
ACROW
688070